COLUMBUS, Ohio — For the first time in five years, a new drug for ALS, commonly known as Lou Gehrig’s Disease, which affects the nervous system, was approved.
Dr. Adam Quick, a neurologist at the Ohio State University Wexner Medical Center, joined Spectrum News 1 to discuss the FDA approval and the drug.